Squarepoint’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.4K | Sell |
95,617
-99,792
| -51% | -$94.4K | ﹤0.01% | 2515 |
|
|
2025
Q1 | $90K | Buy |
+195,409
| New | +$90K | ﹤0.01% | 2542 |
|
|
2024
Q4 | – | Sell |
-188,842
| Closed | -$296K | – | 3046 |
|
|
2024
Q3 | $296K | Buy |
+188,842
| New | +$296K | ﹤0.01% | 2005 |
|
|
2023
Q4 | – | Sell |
-62,243
| Closed | -$67.8K | – | 2765 |
|
|
2023
Q3 | $67.8K | Buy |
+62,243
| New | +$67.8K | ﹤0.01% | 2300 |
|
|
2023
Q2 | – | Sell |
-23,938
| Closed | -$58.2K | – | 2652 |
|
|
2023
Q1 | $58.2K | Sell |
23,938
-3,326
| -12% | -$8.08K | ﹤0.01% | 2092 |
|
|
2022
Q4 | $52.1K | Buy |
+27,264
| New | +$52.1K | ﹤0.01% | 2142 |
|
|
2022
Q2 | – | Sell |
-26,189
| Closed | -$55K | – | 2419 |
|
|
2022
Q1 | $55K | Sell |
26,189
-12,576
| -32% | -$26.4K | ﹤0.01% | 2099 |
|
|
2021
Q4 | $153K | Buy |
38,765
+26,451
| +215% | +$104K | ﹤0.01% | 2196 |
|
|
2021
Q3 | $59K | Sell |
12,314
-438
| -3% | -$2.1K | ﹤0.01% | 2089 |
|
|
2021
Q2 | $59K | Sell |
12,752
-74,745
| -85% | -$346K | ﹤0.01% | 2493 |
|
|
2021
Q1 | $514K | Buy |
87,497
+71,858
| +459% | +$422K | ﹤0.01% | 1506 |
|
|
2020
Q4 | $53K | Sell |
15,639
-152,515
| -91% | -$517K | ﹤0.01% | 2421 |
|
|
2020
Q3 | $242K | Buy |
168,154
+29,239
| +21% | +$42.1K | ﹤0.01% | 1826 |
|
|
2020
Q2 | $277K | Sell |
138,915
-122,614
| -47% | -$244K | ﹤0.01% | 1604 |
|
|
2020
Q1 | $510K | Buy |
261,529
+155,640
| +147% | +$304K | 0.01% | 1025 |
|
|
2019
Q4 | $439K | Buy |
+105,889
| New | +$439K | ﹤0.01% | 1794 |
|
|
2019
Q3 | – | Sell |
-54,999
| Closed | -$346K | – | 2425 |
|
|
2019
Q2 | $346K | Sell |
54,999
-19,654
| -26% | -$124K | ﹤0.01% | 1813 |
|
|
2019
Q1 | $415K | Buy |
74,653
+48,660
| +187% | +$271K | ﹤0.01% | 1557 |
|
|
2018
Q4 | $173K | Buy |
+25,993
| New | +$173K | ﹤0.01% | 1713 |
|
|
2018
Q2 | – | Sell |
-19,928
| Closed | -$171K | – | 1921 |
|
|
2018
Q1 | $171K | Buy |
+19,928
| New | +$171K | ﹤0.01% | 1515 |
|
|
2017
Q4 | – | Sell |
-14,556
| Closed | -$179K | – | 2223 |
|
|
2017
Q3 | $179K | Sell |
14,556
-1,960
| -12% | -$24.1K | ﹤0.01% | 1402 |
|
|
2017
Q2 | $272K | Buy |
+16,516
| New | +$272K | 0.01% | 1166 |
|
|
2016
Q4 | – | Sell |
-10,800
| Closed | -$195K | – | 1847 |
|
|
2016
Q3 | $195K | Buy |
+10,800
| New | +$195K | 0.01% | 898 |
|
|
2016
Q2 | – | Sell |
-17,980
| Closed | -$215K | – | 1248 |
|
|
2016
Q1 | $215K | Sell |
17,980
-8,520
| -32% | -$102K | 0.02% | 970 |
|
|
2015
Q4 | $353K | Buy |
+26,500
| New | +$353K | 0.04% | 719 |
|